INITIAL EXPERIENCE WITH ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN A BRAZILIAN CANCER CENTER BB Bal; BA Souza; JF Campos; JA Balthazar; GA Peruzini; ML Garcia; LM Brandão; NM Santana; AC Cordeiro; VA Bovolenta; TRC Fisher; TMB Silveira; MM Nascimento; JS Filho;

INITIAL EXPERIENCE WITH ANTI-CD19 CAR-T CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A SERIES OF CASES IN A BRAZILIAN CANCER CENTER NM Santana; ML Garcia; JA Balthazar; GA Peruzini; LM Brandão; BA de Souza; JF Campos; JC Amarante; AGO Braga; AC Cordeiro; VA Bovolenta; MM Nascimento; JS Filho;

MODIFICATIONS IN RISK CLASSIFICATION OF ACUTE MYELOID LEUKEMIAS UNDERGOING LESS INTENSIVE CHEMOTHERAPY COMPARING THE 2022 AND 2024 STRATIFICATIONS OF THE EUROPEAN LEUKEMIANET AND THEIR IMPACT ON TREATMENT DECISION, RESPONSE RATES AND OUTCOMES OF A BRAZILI LM Brandão; JA Balthazar; NM Santana; B Aires; ML Garcia; GA Peruzini; BB Cal; JF Campos; AG Braga; JC Amarante; V Bovolenta; MM Nascimento; JS Filho;